Dan Deardorf Presents Glycologix at LSI USA '23

Glycologix is developing a non-systemic, highly cross-linked chondroitin sulfate-based biopolymer platform for soft tissue protection and repair.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Dan Deardorf
Dan Deardorf
CEO, Glycologix